Genetic Testing in Urinary Tract Cancers Gayun Chan-Smutko INTRODUCTION Cancers of the urinary tract include renal cell carcinoma (RCC) and transitional cell carcinoma, or urothelial carcinoma (UC). About 64,770 cases…
Molecular Biology of Bladder Cancer Margaret A. Knowles Carolyn D. Hurst INTRODUCTION There has been rapid progress in elucidating the molecular changes that underlie bladder cancer development. A wealth of…
Cancer of the Kidney Brian R. Lane Daniel J. Canter Brian I. Rini Robert G. Uzzo INTRODUCTION Cancer of the kidney is neither common enough to cause a large percentage…
Molecular Biology of Kidney Cancer W. Marston Linehan Laura S. Schmidt INTRODUCTION Kidney cancer or renal cell carcinoma (RCC) affects more than 271,000 people annually worldwide, resulting in 116,000 deaths…
Genetic Counseling Ellen T. Matloff Danielle C. Bonadies INTRODUCTION Clinically based genetic testing has evolved from an uncommon analysis ordered for the rare hereditary cancer family to a widely available…
Cancer Screening Otis W. Brawley Howard L. Parnes INTRODUCTION Cancer screening refers to a test or examination performed on an asymptomatic individual. The goal is not simply to find cancer…
Cancer Risk-Reducing Agents Dean E. Brenner Scott M. Lippman Susan T. Mayne WHY CANCER PREVENTION AS A CLINICAL ONCOLOGY DISCIPLINE Until recently, clinical oncology has been defined as a medical…
Role of Surgery in Cancer Prevention José G. Guillem Andrew Berchuck Jeffrey F. Moley Jeffrey A. Norton Sheryl G. A. Gabram-Mendola Vanessa W. Hui INTRODUCTION Since the heritable component of…
Tobacco Use and the Cancer Patient Graham W. Warren Benjamin A. Toll Irene M. TamÃ-Maury Ellen R. Gritz INTRODUCTION Tobacco is commonly described as the largest preventable cause of cancer….
Assessment of Clinical Response Antonio Tito Fojo Susan E. Bates INTRODUCTION Approaches to response assessments have become increasingly important over the past decade as the drug development pipeline has steadily…
